Chronic kidney disease. Chronic kidney disease (CKD)
Conditions
Interventions
Intervention 1: Intervention group: 65 patients in the intervention group will receive 40 mg oral zinc supplement (Dana Pharmaceutical Company) twice a day for three months in addition to their main d
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: At least 3 months have passed since their dialysis Dialyses at least 2 times a week Age above 18 years
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding Suffering from other chronic diseases Blood transfusion or bleeding during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: Before starting the study and twice a week for three months. Method of measurement: Using electronic pressure gauge Citizen CH 304 (Japan).;?Diastolic blood pressure. Timepoint: Before starting the study and twice a week for three months. Method of measurement: Using electronic pressure gauge Citizen CH 304 (Japan). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Aziminejad
Arak University of Medical Sciences
Outcome results
None listed